Patents matching “The United States of America”

US 6797275

Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 28, 2004 · Expires Sep 23, 2024

US 6797276

Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response

The United States of America as represented by the Secretary of the Army · Granted Sep 28, 2004 · Expires Sep 23, 2024

US 6793927

Construction of Pasteurella haemolytica vaccines

The United States of America as Represented by the Secretary of the Department of Agriculture · Granted Sep 21, 2004 · Expires Sep 16, 2024

US 6794174

Full-length infectious cDNA clones of tick borne flavivirus

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 21, 2004 · Expires Sep 16, 2024

US 6794498

Method of eliminating inhibitory/instability regions of mRNA

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 21, 2004 · Expires Sep 16, 2024

US 6794188

Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells and therapeutic uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 21, 2004 · Expires Sep 16, 2024

US 6790449

Methods for producing self-replicating infectious RSV particles comprising recombinant RSV genomes or antigenomes and the N, P, L, and M2 proteins

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 14, 2004 · Expires Sep 9, 2024

US 6790936

CAI resistance proteins and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 14, 2004 · Expires Sep 9, 2024

US 6787145

Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 7, 2004 · Expires Sep 2, 2024

US 6787333

Retrovirus isolated from humans

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 7, 2004 · Expires Sep 2, 2024

US 6780413

Immunotoxin (mAB-RICIN) for the treatment of focal movement disorders

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 24, 2004 · Expires Aug 19, 2024

US 6780847

Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 24, 2004 · Expires Aug 19, 2024

US 6780417

Transmission blocking immunogen from malaria

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 24, 2004 · Expires Aug 19, 2024

US 6773880

Streptococcus pneumoniale 37-kDa surface adhesion A protein

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 10, 2004 · Expires Aug 5, 2024

US 6770479

Anthrax vaccine

The United States of America as represented by the Secretary of the Army · Granted Aug 3, 2004 · Expires Jul 29, 2024

US 6770291

Liposome complexes for increased systemic delivery

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 3, 2004 · Expires Jul 29, 2024

US 6767546

Use of echinacea as a feed additive to enhance protection against coccidiosis

The United States of America, as represented by the Secretary of Agriculture · Granted Jul 27, 2004 · Expires Jul 22, 2024

US 6765104

Transition metal complexes of n, n',n″trialkyl-cis-1,3,5-triaminocyclohexane and related compositions and methods of synthesis and use

The United States of America, as represented by the Department of Health and Human Services · Granted Jul 20, 2004 · Expires Jul 15, 2024

US 6761911

Use of chlorate ion or preparations thereof for reduction of food borne pathogens

The United States of America, as represented by the Secretary of Agriculture · Granted Jul 13, 2004 · Expires Jul 8, 2024

US 6756038

Agonist and antagonist peptides of carcinoembryonic antigen (CEA)

The United States of America, as represented by the Department of Health and Human Services · Granted Jun 29, 2004 · Expires Jun 24, 2024

US 6756399

Use of lipoxygenase inhibitors and PPAR ligands as anti-cancer therapeutic and intervention agents

The United States of America, as represented by the Department of Health and Human Services · Granted Jun 29, 2004 · Expires Jun 24, 2024

US 6756201

Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1

The United States of America as represented by the Department of Health and Services · Granted Jun 29, 2004 · Expires Jun 24, 2024

US 6753317

Dmt-Tic di- and tri-peptide derivatives and related compositions and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Jun 22, 2004 · Expires Jun 17, 2024

US 6750254

Nitric oxide-releasing amidine—and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same

The United States of America, as represented by the Department of Health and Human Services · Granted Jun 15, 2004 · Expires Jun 10, 2024